INTERCEPT: Identifying and Managing Cancer Treatment Cardiotoxicities in Patients Undergoing Therapy: Cardiovascular Risk for the Cancer Journey -Enduring

A curriculum designed to engage clinicians in an educational initiative aimed at improving the overall care for cancer patients at risk for cardiotoxicity associated with their treatment. This program is part 2 of 4 enduring webinars provided by expert clinical faculty.

Learning Objectives

1|Review recent data on cytotoxic chemotherapies, targeted therapies, and immunotherapies known to cause cardiotoxicity in cancer patients

2|Discuss the use of clinical tools, imaging, and other tests to evaluate patients at risk for cardiotoxicity before, during, and after cancer treatment

3|Employ multidisciplinary strategies to mitigate the risk for cardiotoxicity in cancer patients

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
Registration Opens: 
06/14/2021
Registration Expires: 
06/13/2023
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
Please login or register to take this course.